Research Type: Academic Literature

Academic literature is reviewed by peer experts in a scientific field before it is approved for publication. The acceptance of our opinions and research after this vetting process indicates its relevance to current policies and other important drug and device issues.

What A Waste! The National Academy Of Medicine’s Report On Oversized Vials Of Expensive Drugs
Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy
CMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing of Drugs
Priceless Knowledge: Attitudes and Awareness Around Drug Pricing Among US Medical Students
Who Is Sowing Seeds of Confusion About The QALY?
Pharmaceutical Products and Their Value: Lessons Learned and the Path Ahead
DPL, Commonwealth Fund and Health Affairs Release Policy Papers
US Drug Prices And R&D, Take 2: A Reply To Grabowski And Manning, And To Light
Eli Lilly Announces Additional Vial Size to Minimize Waste
Dr. Peter Bach Explains How Increasing Drug Prices Stifles Innovation

Research Type: Academic Literature

What A Waste! The National Academy Of Medicine’s Report On Oversized Vials Of Expensive Drugs

Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy

CMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing of Drugs

Priceless Knowledge: Attitudes and Awareness Around Drug Pricing Among US Medical Students

Who Is Sowing Seeds of Confusion About The QALY?

Pharmaceutical Products and Their Value: Lessons Learned and the Path Ahead

DPL, Commonwealth Fund and Health Affairs Release Policy Papers

US Drug Prices And R&D, Take 2: A Reply To Grabowski And Manning, And To Light

Eli Lilly Announces Additional Vial Size to Minimize Waste

Dr. Peter Bach Explains How Increasing Drug Prices Stifles Innovation